9æ30æ¥ã®Moderna Inc (MRNA) å§å€ã¯6.27%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
Moderna Inc (MRNA) å§å€ã¯6.27%äžèœããŸãããå»è¬å & å»çç ç©¶ã»ã¯ã¿ãŒã¯0.34%äžèœããŠããŸãããã®äŒæ¥ã¯æ¥çå¹³åãäžåããŸãããã»ã¯ã¿ãŒå ã®å£²è²·ä»£éäžäœ3éæïŒModerna Inc (MRNA) äžèœ 6.27%ãEli Lilly and Co (LLY) äžæ 0.04%ãBristol-Myers Squibb Co (BMY) äžæ 0.65%ã

æ¬æ¥ã®Moderna IncïŒMRNAïŒã®æ ªäŸ¡äžèœã®èŠå ã¯äœã§ããïŒ
ã¢ãã«ãã¯ãæ°é±éã«ãããæ¥æ¿ãªäžæã©ãªãŒã®åŸãäž»èŠãªã»ã«ãµã€ãæ©é¢ã«ããæ³šç®ã®æ Œäžããäž»å ãšãªãã匷ã売ãå§åã«çŽé¢ããŸããããŠã©ãŒã«è¡ã®äž»èŠéèæ©é¢ã¯ãåãã€ãªãã¯ãããžãŒäŒæ¥ã®æè³å€æãã売ãããžãšåŒãäžããåžå ŽäŸ¡å€ããã¡ã³ãã¡ã³ã¿ã«ãºã®å®æ ããä¹é¢ããŠãããšææããŸãããã¢ããªã¹ããã¯ãåå¥åããæ²»ççšmRNAã¯ã¯ãã³åè£ã®èšåºè©Šéšã®é²å±ã«å¯ŸããæåŸ ãè¶³å ã®æ ªäŸ¡æ¥éš°ãçœåŒãããã®ã®ãããã«ããããªã¥ãšãŒã·ã§ã³åçãæç¶äžå¯èœãªæ°ŽæºãŸã§æŒãäžãããããšåŒ·èª¿ããŸããããŠã©ãŒã«è¡ã®ãªãµãŒãã¯ãçŸå®çãªåçã¢ãã«ãçæçãªãã£ãã·ã¥ãããŒèŠéããå€§å¹ ã«äžåãã倿§ãªããçš®ã§ã®åºç¯ãªåçšæ®åãåžå ŽæåŸ ãç¹ã蟌ãã§ãããšææããæ©é¢æè³å®¶ã«ä¿æããžã·ã§ã³ã®åè©äŸ¡ãä¿ããŸããã
ããªã¥ãšãŒã·ã§ã³ã«å¯ŸããåŠå®çãªã»ã³ãã¡ã³ãã«æè»ããããããã«ãæ³çãªäžç¢ºå®æ§ã®åçãå瀟ã®å€§ããªé颚ãšãªã£ãŠããŸãããã©ãŠã§ã¢å·é£éŠå°æ¹è£å€æã¯æè¿ãåºå¹¹çãªmRNAæè¡ã«é¢ããé²è¡äžã®ç¹èš±äŸµå®³èšŽèšã«ãããŠãäž»èŠãªèšŽãã®åŽäžãæ±ããã¢ãã«ãã®ç³ç«ãŠãéããŸããããã®æ³çãªã€ãŸããã¯ãåžå Žãå瀟ã®è²¡åç¶æ³ã粟æ»ããŠããããªãã«ã蚎èšãªã¹ã¯ãæœåšçãªè²¡åè² æ ãããããããšã«ãªããŸããå瀟ã®éçºãã€ãã©ã€ã³ãé²å±ããäžæ¹ã§ãäžæ žäºæ¥ã¯åæäžä»£ã¯ã¯ãã³ã®åæ¥éèŠäœè¿·ãç¶ç¶çãªãã£ãã·ã¥ããŒã³ãããã³èµ€åç¶æ ãšãã£ãé颚ã«åŒãç¶ãçŽé¢ããŠãããçæçãªåçåã«å¯Ÿããã¢ããªã¹ãã®æççãªèŠæ¹ã匷ããŠããŸãã
ååŒååã®èгç¹ããã¯ãã¢ã¡ã³ã¿ã ã«äž»å°ãããé·æã®äžæå±é¢ãçµãåŸã®å©ç確å®å£²ãããæ ªäŸ¡ã®äžèœãããã«å éãããŸãããçµå¶å¹¹éšã«ããäºåèšå®ã«åºã¥ãã€ã³ãµã€ããŒæ ªåŒå£²åŽã®è©³çްãæèšããæè¿ã®èŠå¶éç€ºææžããåžå Žã®èŠææãé«ããèŠå ãšãªããŸããããã¯ãã«ã«ãªã¢ã¡ã³ã¿ã ãéåããã«ã€ããæ©é¢æè³å®¶ã®ãªãã©ã³ã¹ãçæè³éã®ååãæ¥äžã®å€§å¹ ãªãã©ãã£ãªãã£ãåŒãèµ·ãããŸãããæè³å®¶ã¯ãææ©çãªããªã¥ãšãŒã·ã§ã³ã»ãã¬ãã¢ã ããããéçºãã€ãã©ã€ã³è³ç£ã®æç¢ºãªåçåã®èšŒæ ãäžæ®µãšæ±ããããã«ãªã£ãŠããããããåç€Ÿæ ªãžã®åŒ·ãäžèœå§åã«ã€ãªãã£ãŠããŸãã
Moderna IncïŒMRNAïŒã®ãã¯ãã«ã«åæ
æè¡çã«èŠããšãModerna Inc (MRNA)ã¯MACDïŒ12,26,9ïŒã®æ°å€ã3.905ã§ãè²·ãã®ã·ã°ãã«ã瀺ããŠããŸããRSIã¯69.151ã§äžç«ã®ç¶æ ãWilliamsïŒ Rã¯20.453ã§è²·ãã®ç¶æ ã瀺ããŠããŸãããæ³šæãã ããã
Moderna IncïŒMRNAïŒã®ã¡ãã£ã¢å ±é
ã¡ãã£ã¢å ±éã«é¢ããŠãModerna Inc (MRNA)ã¯ã¡ãã£ã¢æ³šç®åºŠã¹ã³ã¢63ã瀺ããŠãããã¡ãã£ã¢æ³šç®åºŠã¯é«ãã¬ãã«ã§ããå šäœã®åžå Žã»ã³ãã¡ã³ãææ°ã¯çŸåšæ¥µç«¯ãªåŒ·æ°ãŸãŒã³ã«ãããŸãã

Moderna IncïŒMRNAïŒã®ãã¡ã³ãã¡ã³ã¿ã«åæ
Moderna Inc (MRNA)ã¯å»è¬å & å»çç ç©¶æ¥çã«å±ããŠããŸããææ°ã®å¹Žé売äžé«ã¯$1.94Bã§ãæ¥çå ã§39äœã§ããçŽå©çã¯$-2.82Bã§ãæ¥çå ã§ã¯195äœã§ããäŒç€ŸæŠèŠ

éå»1ãæã§è€æ°ã®ã¢ããªã¹ããå瀟ãäžç«ãšè©äŸ¡ããŸãããç®æšæ ªäŸ¡ã®å¹³åã¯$117.66ãæé«ã¯$170.00ãæäœã¯$40.00ã§ãã
Moderna IncïŒMRNAïŒã«é¢ãã詳现
äŒæ¥åºæã®ãªã¹ã¯ïŒ
- ããªã¥ãšãŒã·ã§ã³éç±ã«äŒŽãã»ã«ãµã€ãã®æè³å€æåŒãäžãïŒã·ãã£ã¯ã¢ãã«ãã®æè³å€æãã売ããã«åŒãäžããç®æšæ ªäŸ¡ã80ãã«ã«èšå®ãããæ ªäŸ¡ã®æè¿220%è¶ ã®äžæã«ã€ããŠãå瀟ã®ããã¯ã¯ãã³ãintismeran autogeneãã«å¯Ÿãã260åãã«ãšããé床ã«åŒ·æ°ãªæœåšç売äžé«ã®è©Šç®ã«åºã¥ããŠããããããã¯æ£å³çŸåšäŸ¡å€ïŒNPVïŒã¢ãã«ãå€§å¹ ã«äžåã£ãŠãããæ£åœåã§ããªãããªã¥ãšãŒã·ã§ã³ãçã¿åºããŠãããšèŠåããŠããã
- é£éŠç¹èš±èšŽèšã«ãããäžå©ãªå€æ±ºïŒãã©ãŠã§ã¢å·é£éŠå°æ¹è£å€æã¯ãmRNAã®ç¥ç財ç£ã«é¢ããŠãã€ãšã«ã®ã¢ã³ãµã³ãéšéãæèµ·ããç¹èš±äŸµå®³èšŽèšã«ã€ããŠãã¢ãã«ãã«ãã蚎èšåŽäžã®ç³ç«ãŠãæ£åŽãããããã«ãããåç€Ÿã¯æ°ããªæ³ç責任ãå°æ¥çãªãã€ã€ãªãã£è² æ ã®å¯èœæ§ã«æãããŠããã
- 瀟åµçºè¡èп𡿡倧ã«ããæ ªåŒã®åžèåïŒã¢ãã«ãã¯2032å¹Žæºæã®åªå 転æç€Ÿåµã®çºè¡èŠæš¡ã26åãã«ã«å¢é¡ãããå瀟ããã€ãã¹ã®çŽãã£ãã·ã¥ãããŒã§äºæ¥éå¶ãç¶ããäžãæ ªåŒè»¢ææã®æœåšçãªæ ªåŒåžèåãè³æ¬çŸ©åã®å¢å ã«å¯ŸããŠæ©é¢æè³å®¶ã®æžå¿µãé«ãŸã£ãŠããã
- äºæ¥æšé²äžã®ããŒãã«ãšé ã忥åã®ã¿ã€ã ã©ã€ã³ïŒãªãŒãªã³ã¯ãšãã¹ãã£ã€ã«ãã»ã¬ããããŒã³ã®ã¢ããªã¹ãã¯ãæè¿ã®æ²»éšã«ããããã€ã«ã¹ããŒã³éæããå®éã®å£²äžé«å®çŸãŸã§ã®éã«ã¯æ°å¹Žã«åã¶èŠå¶åœå±ã®æ¿èªãšåæ¥åã®ç«ã¡äžããå¿ èŠã§ãããšææããéçºãã€ãã©ã€ã³ã®é å»¶ãã¯ã¯ãã³ã®å£ç¯çãªå£²äžå€åã«å¯ŸããŠæ ªäŸ¡ãè匱ãªç¶æ ã«ãããšåŒ·èª¿ããŠããã
ãã®èšäºã®äžéšã¯AIã«ãã£ãŠçæã»ç¿»èš³ããã人éã«ããã¬ãã¥ãŒãçµãŠããŸããããã¯äžè¬çãªæ å ±æäŸã®ç®çã§ã®ã¿äœ¿çšãããŠãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸããã
ããããèšäº









ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã